Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
25 mars 2024 16h56 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
21 mars 2024 10h31 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
Asia-Pacific Organ Transplant Diagnostics Market Forecast to Reach $3.45 Billion by 2033 - Advancements in Human Leukocyte Antigen (HLA) Typing Tests Present Opportunities
08 mars 2024 09h37 HE
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Organ Transplant Diagnostics Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.In...
Bionic Devices Market Report 2024-2030: Lucrative Opportunities in Auditory Bionic/Cochlear Implants
05 mars 2024 11h20 HE
|
Research and Markets
Dublin, March 05, 2024 (GLOBE NEWSWIRE) -- The "Bionic Devices Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has...
Europe Organ Transplant Diagnostics Market - Comprehensive Analysis and Forecast 2023-2033
30 janv. 2024 04h54 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Organ Transplant Diagnostics Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The Europe...
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
29 nov. 2023 16h05 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
United States Regenerative Medicine Market Report 2023: Competition, Forecasts and Opportunities, 2018-2028
28 nov. 2023 09h53 HE
|
Research and Markets
Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The "United States Regenerative Medicine Market, Competition, Forecast and Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's...
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
09 nov. 2023 16h01 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
02 nov. 2023 09h05 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer
23 oct. 2023 07h00 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer